Pharma News - Chemdiv

Zealand Pharma Announces Positive Results from Phase 3 Trial of Dasiglucagon in Pediatric Patients with Congenital Hyperinsulinism (CHI)

Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced positive top-line resul...

Ultragenyx Gains Rights to Abeona Therapeutics’ Gene Therapy for Rare Disease

Ultragenyx Pharmaceutical is acquiring exclusive global rights to Abeona Therapeutics’ investigational adeno-associated virus (AAV) gene therapy ABO-102.

FDA declines to grant EUA for antidepressant to treat Covid-19

The data was inadequate to conclude that the drug was effective in preventing disease progression, FDA noted.

Drug treatment for cataracts moves a step closer

A revolutionary new treatment for cataract has shown extremely positive results in laboratory tests, giving hope that the condition, that currently can only be cured with surgery, could soon be tre...

U.S. says use of Pfizer's COVID-19 antiviral up 315%

Use of Pfizer Inc’s (PFE.N) COVID-19 oral antiviral treatment Paxlovid has jumped 315% over the past four weeks, the U.S. Department of Health and Human Services said on Tuesday, as health offici...

MHRA Approves Verzenios for Certain Types of Early Breast Cancer

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization to Eli Lilly’s Verzenios (abemaciclib) in combination with endocrine therapy for adjuvant...

Evotec, Sernova Striving for Functional Diabetes Cure

Two life sciences powerhouses are coming together to develop an off-the-shelf beta cell replacement therapy for insulin-dependent diabetes patients, which they hope will become a functional cure f...

Otsuka Ends Partnership With Akebia Over CRL-Related CKD Anemia Drug

Otsuka Pharmaceutical said it is ending a collaboration with Akebia Therapeutics over the investigational chronic kidney disease-associated anemia drug vadadustat. ...

NICE Recommends AstraZeneca’s Imfinzi for NSCLC

The UK’s National Institute for Health and Care Excellence (NICE) is recommending AstraZeneca’s Imfinzi (durvalumab) for National Health Service (NHS) use in treating patients with locally adva...

FDA Authorizes First COVID-19 Test Available without a Prescription That Also Detects Flu and RSV

Today, the U.S. Food and Drug Administration authorized the Labcorp Seasonal Respiratory Virus RT-PCR DTC Test for use without a prescription by individuals with symptoms of respiratory viral infec...

Fujirebio’s Diagnostic Test for Beta-amyloid Plaques Given FDA OK

The U.S. Food and Drug Administration (FDA) has granted marketing permission to a new test that checks for amyloid plaques in people being checked for Alzheimer’s disease. ...

Flu causes cardiac complications by directly infecting the heart

Researchers have shown for the first time in mice that heart problems associated with the flu are not caused by raging inflammation in the lungs, as has long been predicted. ...

Pharma News, 2022